Hestia Insight Inc. Enters into Memorandum of Understanding to Obtain Exclusive License to Brain Health and Functionality Technologies for the Treatment of Mental Health Conditions
December 29, 2021 at 06:00 am EST
Hestia Insight Inc. announced its execution of a Memorandum of Understanding with General Data Collection Ltd. (GDC), pursuant to which Hestia Insight and GDC have agreed in principle to enter into license agreements whereby GDC would grant to Hestia Insight, on an exclusive, non-revocable, royalty-free, and perpetual basis, licenses in certain of GDC's technologies relating to the treatment of mental health conditions using electromagnetic brain pulse (EMBP) protocols and products (collectively, the "Technologies"), in order for Hestia Insight to exclusively develop, make, have made, market, and sell brain health and functionality products and services using such Technologies within the United States. According to the National Institute of Mental Health, nearly one in five U.S. adults lives with some kind of mental illness. GDC developed Electromagnetic Brain Pulsing (EMBP), a non-invasive, brain-wave-guided transcranial magnetic stimulation treatment, which focuses on the brains physical condition and treats the neurons in the brain to restore optimal neurological functionunder the care of a licensed physician. EMBP was initially released through GDCs wholly-owned subsidiary, Noether Sciences and Technologies Inc., with the goal of identifying and recording individual brain activity and to improve or correct brain condition through pulse-matching, electromagnetic stimulation. EMBP has been used to treat depression disorder, anxiety disorder, attention deficit hyperactivity disorder, and substance abuse disorders, including addiction.